Page 266 - Drug Class Review
P. 266

Page 163 of 205
             Drug Effectiveness Review Project


































                                                           Primary Outcome Measures: Adverse events noted during 6 months after first prescription for DON  Timing of assessments: 6 months after first prescription for the drug










                                 Groups similar at baseline: N/A

                                    Alzheimer classification: NR
                                                                               Health Outcome Measures:   NR



                                        donepezil   72.9   58   NR   NR   Secondary Outcome Measures: NR   See adverse events (incidence > 5% reported)   Intermediate Outcome Measures:













                                                                                  •         •














             Final Report Update 1     Authors: Dunn et al.   Year: 2000   POPULATION  CHARACTERISTICS:       Mean age (years):   Sex (% female):   Ethnicity:  Other germane population qualities:     OUTCOME ASSESSMENT:          RESULTS:     Alzheimer's Drugs
   261   262   263   264   265   266   267   268   269   270   271